The RDAF publishes its newsletter

    29 Jun, 2022

    The newsletter, which is published twice a year, gives an overview of all the Rare Disease Action Forum (RDAF) activities during the past half year to raise awareness about rare diseases in Switzerland and improve patient’s access to diagnosis, treatment and care. Activities in Q1-Q2 2022 include:

    • Policy monitoring and evaluation,
    • Multi-stakeholder workshop on market access for orphan drugs in Switzerland,
    • Engagement with key stakeholders in the field of rare diseases.

    The newsletter also includes an outlook of upcoming RDAF activities for Q3-Q4. The RDAF will submit its input for the ongoing public consultation on the revision of the Health Insurance and Benefits Ordinances. The RDAF will also organize a webinar in Q4 2022. The full newsletter is available here.

    Continue reading

    RDAF hosts multi-stakeholder workshop on post-marketing registries

    The Rare Disease Action Forum (RDAF) will host a multi-stakeholder workshop on post-marketing registries for rare diseases on 21 September 2023 (14.00 – 19.00 CEST) in Basel, Switzerland. The workshop will gather stakeholders active in the rare disease field to...

    RDAF Newsletter

    We just released the first issue of the RDAF newsletter, which gives an overview of key policy developments and RDAF activities in the first half of the year. Highlights include: Overview of the latest policy developments relevant for the rare disease field...